bioCSL supports public health efforts in Laos with donation of more than 700,000 doses of seasonal influenza vaccine

Participation in innovative public-private collaboration helps improve vaccination infrastructure, expand patient reach in partner countries April 28, 2014 bioCSL, formerly CSL Biotherapies, has announced the donation of more than 700,000 doses of its influenza vaccine to the¬†Partnership for Influenza Vaccine Introduction, an innovative program – spearheaded by the U.S. Centers for Disease Control and Prevention (CDC) and the Task Force …